Motus GI

Motus GI is a medical technology company developing advanced endoscopic solutions for the minimally invasive diagnosis and treatment of gastrointestinal disorders.

Health Tech & Life Sciences
Public on NASDAQ on Feb, 2018
Public Fort Lauderdale, United States Founded 2008
Last updated 2026-07-27
Total raised
$76.5M
Last: Public Offering 2023-05
Stage
Public
Founded
2008
Headcount
15
HQ
Fort Lauderdale, United States
Sector
Health Tech & Life Sciences

About

Motus GI Holdings, Inc. is a medical technology company with subsidiaries in the U.S. and Israel, dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy and upper GI endoscopy. The company's flagship product is the Pure-Vu® System, a U.S. FDA cleared medical device that facilitates the cleaning of a poorly prepared gastrointestinal tract during endoscopy procedures. The Pure-Vu® System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during procedures while preserving established procedural workflow and techniques. The company aims to improve outcomes and lower costs for hospitals by reducing the time to successful procedures, minimizing delayed and incomplete procedures, and improving the quality of an exam.

Funding history · 5 rounds · $76.5M total

2023-04
PIPE $3.5M
2021-07
Debt Financing $12.0M
★ Kreos CapitalKreos Capital VI LP
2018-02
Follow-on PO $17.5M
★ Oppenheimer & Co.★ Piper Jaffray & Co.★ Piper Jaffray Companies
2017-02
B Round $30.0M
★ GJG Life Sciences★ Perceptive Advisors★ SternAegis Ventures★ Pura Vida Investments★ Jacobs Investment Company★ Ascent Biomedical Ventures★ Orchestra Medical Ventures
2011-08
A Round $13.5M

Headcount over time

From 31 (2018-09) to 21 (2026-03) · -10 (-32%) · 49 points · source: Finder history + radar grounding
540 2018-09 2026-03

Q&A

What is Motus GI's primary product?
Motus GI's flagship product is the Pure-Vu® System, a U.S. FDA cleared medical device designed to clean a poorly prepared gastrointestinal tract during endoscopy procedures, improving visualization.
When did Motus GI go public?
Motus GI became a public company on NASDAQ in February 2018.
What was the amount raised in Motus GI's initial public offering?
In February 2018, Motus GI raised $17,500,000 through its Public Offering, with.
Has Motus GI received recent FDA clearances for its products?
Yes, in October 2023, Motus GI received FDA clearance to commercialize the Pure-Vu EVS Gastro and Gen 4 Colon systems.
What was a significant debt financing event for Motus GI in 2021?
In July 2021, Motus GI secured $12,000,000 in.
What was the outcome of a European study on Motus GI's Pure-Vu System?
In January 2024, Motus GI Holdings published positive results from a European study demonstrating the second-generation Pure-Vu System's effectiveness in improving visualization for colonoscopy in patients with a history of poor bowel preparation.
What was Motus GI's most recent funding round?
Motus GI's most recent funding round was a Public Offering in May 2023, which raised $3,900,000.

Team · 1

Boris Shtul
Founder · Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Sensing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicescolonoscopygastroenterologycancerhealthcare-providersdiagnosticsearly-detectiondoctorshospitalssensorsmedical-technologiesendoscopy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemotusgi.com
LinkedInlinkedin.com/company/10597881
Facebookfacebook.com/MotusGI
YouTubeyoutube.com/channel/UCxoy2H9FLs2FfNQljgR8rHA

Identifiers & details

Legal nameMotus GI Holdings, Inc.
Former namesBooton
Founded2008
Employees (exact)15
OfficesFort Lauderdale
Market cap$639
Status reasonPublic on NASDAQ on Feb, 2018

Acquisitions & public offerings

TypeDateExchangeTickerAmount
IPO2018-02NASDAQMOTS$17.5M

Radar intelligence

Patents

EPO16

Web history (Wayback)

Domainmotusgi.com

Certificate / subdomain footprint

Subdomains6

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514188135
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2008-10-06
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events0
Registered addressקרן היסוד 22 טירת כרמל